Suppr超能文献

心力衰竭生物标志物检测的评估:统计考虑因素调查。

Evaluation of heart failure biomarker tests: a survey of statistical considerations.

机构信息

Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, White Oak Building 66, Silver Spring, MD 20993, USA.

出版信息

J Cardiovasc Transl Res. 2013 Aug;6(4):449-57. doi: 10.1007/s12265-013-9470-3. Epub 2013 May 14.

Abstract

Biomarkers assessing cardiovascular function can encompass a wide range of biochemical or physiological measurements. Medical tests that measure biomarkers are typically evaluated for measurement validation and clinical performance in the context of their intended use. General statistical principles for the evaluation of medical tests are discussed in this paper in the context of heart failure. Statistical aspects of study design and analysis to be considered while assessing the quality of measurements and the clinical performance of tests are highlighted. A discussion of statistical considerations for specific clinical uses is also provided. The remarks in this paper mainly focus on methods and considerations for statistical evaluation of medical tests from the perspective of bias and precision. With such an evaluation of performance, healthcare professionals could have information that leads to a better understanding on the strengths and limitations of tests related to heart failure.

摘要

评估心血管功能的生物标志物可以包括广泛的生化或生理测量。用于测量生物标志物的医学检测通常在其预期用途的背景下进行测量验证和临床性能评估。本文在心力衰竭的背景下讨论了用于评估医学检测的一般统计原则。在评估测量质量和检测临床性能时,强调了研究设计和分析的统计方面需要考虑的问题。还提供了针对特定临床用途的统计注意事项的讨论。本文中的评论主要侧重于从偏倚和精度的角度对医学检测的统计评估方法和注意事项。通过对性能的这种评估,医疗保健专业人员可以获得相关信息,从而更好地了解与心力衰竭相关的检测的优势和局限性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验